Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.59NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.24.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.17.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.63NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.14.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.13.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HL.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.42.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DZ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DZ.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.14.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DY.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.14.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.14.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.3.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DY.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.48NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.49NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.14.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.4.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EU.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.4.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GS.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GE.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.93NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.4.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GM.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used